What is a Gallbladder Ejection Fraction (EF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Gallbladder Ejection Fraction (EF)?

Gallbladder ejection fraction (GBEF) is a quantitative measure of how much bile the gallbladder empties in response to hormonal stimulation, expressed as a percentage of the total gallbladder volume. 1

Physiologic Basis

  • The gallbladder stores and concentrates bile during fasting, then empties postprandially through coordinated contraction of the gallbladder and simultaneous relaxation of the sphincter of Oddi 1
  • Cholecystokinin (CCK) is the principal hormone controlling gallbladder emptying after meal ingestion, binding to receptors in the gallbladder causing contraction 1
  • GBEF quantifies this contractile function by measuring the percentage of bile expelled from the gallbladder 1

Measurement Methodology

  • GBEF is measured using cholecystokinin-cholescintigraphy (CCK-CS), which involves injecting a radiotracer (Tc-99m hepatobiliary iminodiacetic acid) followed by infusion of sincalide (synthetic CCK analogue) 1, 2
  • The standardized protocol requires infusion of 0.02 μg/kg sincalide over 60 minutes with dynamic imaging and GBEF calculation at 60 minutes 2, 3
  • Rapid infusion (<30 minutes) should be avoided as it causes non-specific abdominal cramping that confounds interpretation 3, 4
  • Alternative methods using fatty meals (half-and-half milk) exist but show wider variability and lower mean GBEF values compared to CCK infusion 5

Normal and Abnormal Values

  • Normal GBEF is defined as ≥38% using the standardized 60-minute sincalide infusion protocol 2, 3, 4
  • The upper limit of normal approaches 100%, with no established clinical significance for high normal values historically 2, 3
  • A GBEF <38% is considered abnormal and indicates impaired gallbladder contractility (hypokinesia) 2
  • Severely reduced values (such as 2%) indicate markedly impaired gallbladder function 2
  • GBEF values decline with age in patients with acalculous biliary symptoms 6

Clinical Applications

  • CCK-CS with GBEF calculation is used to diagnose functional gallbladder disorder (also called biliary dyskinesia or chronic acalculous cholecystitis) in patients with biliary-type pain but no gallstones on ultrasound 1, 2
  • The test helps identify patients who may benefit from cholecystectomy when structural causes of pain have been excluded 1
  • GBEF measurement aids in diagnosing partial biliary obstruction, sphincter of Oddi dysfunction, and chronic gallbladder disease 1
  • Nuclear medicine hepatobiliary imaging with GBEF is accepted under Society of Gastrointestinal and Laparoendoscopic Surgeons guidelines for evaluating pain of biliary origin 1

Important Caveats

  • Patient selection critically impacts test utility—patients should meet Rome III criteria for functional gallbladder disorder (episodes of right upper quadrant/epigastric pain lasting ≥30 minutes, recurring at different intervals, building to steady level, severe enough to interrupt activities) 1
  • Symptom provocation during CCK infusion is not a reliable diagnostic indicator and should not guide management 4
  • The test has limited accuracy in predicting gallbladder pathology, with studies showing poor negative predictive value (23.5%) even with optimal cut-offs 6
  • GBEF is most useful in patients with typical biliary symptoms; its utility is questionable in those with atypical presentations 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gallbladder Ejection Fraction Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gallbladder Ejection Fraction Measurement and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gallbladder Ejection Fraction and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.